Biotech · Private company

Lumosa Therapeutics Co., Ltd.

Track this companyFree. Adds Lumosa Therapeutics Co., Ltd. to your Dealase workspace and tells you when its record changes.

Clinical trials51 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline7

A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS SubjectsPHASE2 · COMPLETED · started Aug 17, 2022ClinicalTrials.gov NCT05403866 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVTPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 11, 2022ClinicalTrials.gov NCT05198323 · fetched Nov 12, 2026
A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy SubjectsPHASE1 · COMPLETED · started Mar 21, 2021ClinicalTrials.gov NCT04809818 · fetched Nov 12, 2026
A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.PHASE1 · COMPLETED · started Jan 31, 2020ClinicalTrials.gov NCT04256434 · fetched Nov 12, 2026
A Study to Evaluate the Safety and Potential Efficacy of LT3001 Drug Product in Subjects With AISPHASE2 · COMPLETED · started Jan 27, 2020ClinicalTrials.gov NCT04091945 · fetched Nov 12, 2026